Neurokinin NK1 receptor antagonists may have therapeutic potential in the treatment of anxiety and depression. Species variants in the NK1 receptor result in reduced affinity of NK1 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback